A study observed that when overweight women with PCOS were treated with the insulin sensitizer rosiglitazone, serum resistin lowered significantly, suggesting that resistin plays a part in adiposity and insulin sensitivity [84]. Here, INS is linked to polycystic ovary syndrome.